Navigation Links
Neutrons poised to play big role in future scientific advances

Subatomic particles called neutrons are poised to play a big role in fighting HIV, slowing global warming, and improving manufacturing processes. The reason: They are the focus of a process called neutron scattering that provides unprecedented ways to study the chemistry of a wide range of important materials, including coal and biological cells, according to a fascinating article in Chemical & Engineering News (C&EN), ACS' weekly newsmagazine.

C&EN Associate Editor Jyllian Kemsley notes that neutrons have properties useful for studying materials. Neutrons are special because they can penetrate deeper into samples than some other probes and can interact with atoms in ways that other particles can't. This gives scientists much more information about the structure and activity of materials than some current tools.

Using neutron scattering, scientists have studied how certain fluids behave under stress, which could lead to improved manufacturing processes and products. The method also has been used by scientists to study biological processes. All three of the neutron user facilities located at government labs in the United States are in various phases of expansion. "With greater knowledge of neutrons' capabilities and increased availability, scientific progress undoubtedly awaits," the article notes.


Contact: Michael Bernstein
American Chemical Society

Page: 1

Related medicine news :

1. Congress Poised to Add Millions of Uninsured Children to Successful, Bipartisan Health Plan
2. Independent Review Organizations Poised to Help Reduce Rising Healthcare Cost
3. Congress Poised to Reauthorize Legislation Aimed at Dramatic Expansion of Global HIV and AIDS Programs
4. YORK Label Poised for Continued Growth with New Equity Partner
5. Southern Home Medicals Encore Medical Staffing Division Poised to Benefit from Major Growth in Nursing Industry
6. Scientific hunch poised to save thousands from toxic fish poisoning
7. Stem Cells Poised to Grow Organs for Transplant : Zannos Grekos, MD Presents Clinical Data of Research with Adult Stem Cells to Physicians at International Regenerative Biomedicine Conference
8. OxygenToGo Is Poised To Help Airlines Struggling With New Portable Oxygen Concentrator Regulations From The U.S. DOT
9. Europe Poised for Exponential Growth in the Digitised Medical Imaging Storage Space, Reveals Frost & Sullivan
10. Video: Bathmate Hydropump Poised to Replace Cialis, Levitra, and Viagra
11. Botox(R) vs. Reloxin(R) -- the Wrinkle Titans Poised for Battle
Post Your Comments:
(Date:12/1/2015)... , ... December 01, 2015 , ... ... 1980s we have seen vast improvements in scientific research and discoveries, leading us ... providing increased hope and relief to those affected by HIV/AIDS. Mediaplanet’s cross-platform edition ...
(Date:12/1/2015)... ... December 01, 2015 , ... The ... been lifted as IMAGE Information Systems launches MED-TAB™ -- the world’s first portable ... Meeting from November 29 to December 4, 2015. , MED-TAB is expected ...
(Date:12/1/2015)... ... December 01, 2015 , ... ... must mark the film for accurate interpretation by the radiologist. The marking utensils ... inventor from Sacramento, Calif., has found a way to alleviate this problem. , ...
(Date:12/1/2015)... San Francisco, CA (PRWEB) , ... December 01, ... ... The Behavioral Health Center of Excellence (BHCOE) today announced that the organization has ... based in San Francisco, with a Distinguished Award. The award celebrates exceptional special ...
(Date:12/1/2015)... ... ... Lutronic, a leading innovator of aesthetic and medical laser and energy-based technology, ... in the United States. Clarity is a Superior Dual Wavelength Platform which combines ... single platform that is easy to own and operate. , For over a ...
Breaking Medicine News(10 mins):
(Date:12/1/2015)... -- CytRx Corporation (NASDAQ: CYTR ), a biopharmaceutical ... that it has reached its enrollment target of 400 ... trial of aldoxorubicin in patients with previously treated soft ... in Q1 2016. The Phase 3 trial is a randomized, ... from the FDA at 79 sites in ...
(Date:12/1/2015)... Dec. 1, 2015  InCarda Therapeutics, Inc. (InCarda), a ... of therapies for cardiovascular conditions via the inhalation route, ... in Australia . InCarda is planning ... Australia in the first half of ... medical centers in Adelaide and ...
(Date:12/1/2015)... , Dec. 1, 2015  Booth #3506 – Claymount is ... the annual meeting of the Radiological Society of ... this year. Based in the Netherlands ... Varian Medical Systems (NYSE: VAR ) and is one ... chambers and solid state automatic exposure control systems for controlling ...
Breaking Medicine Technology: